glp-1 news updates november 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Market Trends | Whitepaper

Semaglutide and the risk of diabetic retinopathy-current perspective

Mental Health Benefits : Beyond the psychological boost of successful weight management, evidence suggests direct effects on mood regulation, with some patients reporting reduced depression and anxiety symptoms

The spectrum of cognitive impairment in Lewy body diseases

Duration of Treatment GLP-1 medications are typically continued long-term: Ongoing treatment: Benefits persist with continued treatment but diminish if the medication is stopped

In addition to weight reduction, Mounjaro can lead to improvements in overall health, such as better blood sugar control and reduced risks associated with obesity, such as high blood pressure and high cholesterol

(29) While this cannot be directly extrapolated to human outcomes, it does provide the beginnings of research that could be promising for reducing joint infections